Sheng Li, MD
Physical Medicine & Rehabilitation · Houston, TXNPI 1376770602
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,370 of the $43,838 with a category attached, or 69.3%. 9 manufacturers reported payments, led by AbbVie at 39.0% of the total. Reporting peaked in 2024 at $18,204 and has fallen 69.0% since, to $5,648 in 2025. Among physical medicine & rehabilitation clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $707.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$17K
- Pacira Pharmaceuticals Incorporated$11K
- Merz Pharmaceuticals, LLC$8K
- Saol International Limited$6K
- Saol Therapeutics Inc.$2K
- Microtransponder, Inc.$162
- plus $267 from 3 others
Across 11 payments — averaging $1556.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pacira Pharmaceuticals Incorporated$17K
What the payments were for
- Consulting fees$30,37069%
- Speaking & faculty fees$4,53010%
- Travel & lodging$6,11114%
- Food & beverage$2,8276%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $17,107 |
| Pacira Pharmaceuticals Incorporated | 23 | $11,210 |
| Merz Pharmaceuticals, LLC | 9 | $7,832 |
| Saol International Limited | 1 | $5,610 |
| Saol Therapeutics Inc. | 2 | $1,650 |
| Microtransponder, Inc. | 1 | $162 |
| Ipsen Biopharmaceuticals, Inc | 1 | $128 |
| Merz North America, Inc. | 2 | $116 |
| Boehringer Ingelheim | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,838 in reported general payments places this provider in the 95th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 17 | $1,124 |
| Gabapentin | 28 | $578 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Houston
- Gerard FranciscoHouston$364K
- Suzanne ManziHouston$143K
- Cindy IvanhoeHouston$111K
- Purvi DesaiHouston$20K
- Jenny LaiHouston$16K
- Tram PhamHouston$8K
- Marie FrandoHouston$7K
- Bo SongHouston$6K
- Jason HuaHouston$6K
- Teresa KaldisHouston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.